Masubuchi Y, Fujita S, Chiba M, Kagimoto N, Umeda S, Suzuki T
Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Chiba University, Japan.
Biochem Pharmacol. 1991;41(6-7):861-5. doi: 10.1016/0006-2952(91)90189-c.
The effect of repetitive oral administration of propranolol on hepatic microsomal drug metabolizing enzyme activities in the rat was investigated. Propranolol ring (4-, 5- and 7-)hydroxylase activities were markedly decreased, but, interestingly, N-desisopropylase activity was increased after propranolol administration. A marked decrease in enzyme activity after propranolol pretreatment was also observed with debrisoquine 4-hydroxylation. In addition, a similar decrease was observed with imipramine 2-hydroxylation which co-segregates with debrisoquine/sparteine type polymorphic drug oxidation, but not with imipramine N-demethylation. These results suggest the selective impairment of debrisoquine 4-hydroxylase by propranolol pretreatment.
研究了大鼠重复口服普萘洛尔对肝微粒体药物代谢酶活性的影响。普萘洛尔环(4-、5-和7-)羟化酶活性显著降低,但有趣的是,给药后N-去异丙基酶活性增加。普萘洛尔预处理后,去甲异喹胍4-羟化也观察到酶活性显著降低。此外,丙咪嗪2-羟化也观察到类似的降低,丙咪嗪2-羟化与去甲异喹胍/鹰爪豆碱型多态性药物氧化共分离,但与丙咪嗪N-去甲基化无关。这些结果表明普萘洛尔预处理对去甲异喹胍4-羟化酶有选择性损害。